News

A round-up of the latest ophthalmic products

Rapid image acquisition and quantitative analysis are possible

Establishing the pattern of management of diffuse diabetic macular oedema in England

New ophthalmic company KalVista Pharmaceuticals has generated £8 million from series A contributed by Novo A/S and SV Life Sciences.

Abbott Medical Optics' Healon EndoCoat has received the European CE Mark of approval.

Luminous, a program created to develop the understanding of retinal vascular diseases, has enrolled its first patient this month.

Using a combination of observation and amblyopia therapy is successful in mild cases of periocular haemangioma of infancy (HOI).

The cytokine, pentoxifylline, is a safe and effective way to control tumor necrosis factor?a (TNF-a) in conjunctiva affected by ocular cicatricial pemphigoid (OCP).

Ciliary sulcus-to-sulcus (STS) diameter is most accurately measured using ultrasound biomicroscopy (UBM).

Rate of retinal tears (RT) and detachments are higher in patients with an acute posterior vitreous detachment (PVD) and vitreous haemorrhage (VH) patients taking anticoagulants.

A study announced the increased reliability of anterior-segment optical coherence tomography (AS-OCT) when used on patients after long-term dark adaptation.

Implantation of a toric IOL after microincision cataract surgery (MICS) is a safe and successful way to correct astigmatism in cataract patients.

Risk factors for long-term vision loss after trabeculectomy included preoperative split fixation on visual fields

A study demonstrated the efficacies of three different artificial tears (AT) and that a combination of these may offer the best solution to corneal surface diseases affecting eye lubrication

There are several factors involved in the success of repeat penetrating corneal transplantation for keratoconus patients.

Prematurity and birth weight are associated with the progression rate of cup-to-disc ratio (C:D).

Intravitreal bevacizumab may be beneficial as a supplemental therapy for retinopathy of prematurity or as monotherapy in certain cases.

Intravenous methylprednisolone (IVMP) should only be used to increase the rate of symptom relief and recovery from optic nerve dysfunction in patients with severe idiopathic orbital inflammation (IOI).

A child's age and laterality are important factors to consider when determining intraocular lens (IOL) power.

Goblet cell transplantation using autologous turbinate nasal mucosa is a promising treatment for severe ocular surface diseases.

Suprachoroidal silicone tube drainage of aqueous humour effectively reduces intraocular pressure (IOP) in glaucoma patients

Looking at some of the innovations that will be on show during the exhibition at ESCRS

Potential agents take several different paths in terms of their therapeutic benefit

Extremely oblique sclerotomy incision (OSI) has a self-sealing effect on sclerotomy wound leakages.

We offer our overview of this year's ESCRS event with some recommendations from EAB member Dr Gunther Grabner.

A study to determine if long-term low IOPs can be achieved safely

Functional outcomes point to success

Scientific evidence demonstrates nutritional supplementation can help macular health

Risk assessment best guide for determining management of pre-perimetric glaucoma

Continuous wave laser (CWL) cornea shrinkage coupled with CXL